Valiant Laboratories Limited
Issue Size (Net)
up to Rs.152.46 Cr
Price Band
Rs.133 to Rs.140 per share
Issue Opens
September 27, 2023
Issue Closes
October 3, 2023

Company Highlights

1.Company Information

Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.

The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.

For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively

2. Objects of the Issue
The Company proposes to utilize the Net Proceeds towards funding of the following objects:

1. Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).

2. Investment in VASPL for funding its working capital requirements.

3. General corporate purposes.

3.Valiant Laboratories IPO Registrar
Link Intime India Private Ltd

Phone:+91-22-4918 6270

Email: valiantlaboratories.ipo@linkintime.co.in

Website: https://linkintime.co.in/mipo/ipoallotment.html

Valiant Laboratories Limited IPO Financial Information (Restated)

Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Amount in Rs. Crore

Valiant Laboratories IPO Details

Issue Opening Date
September 27, 2023
Issue Closing Date
October 3, 2023
Face Value
Rs.10 per share
Rs.133 to Rs.140 per share
Lot Size
Issue Size
10,890,000 shares (aggregating up to Rs.152.46 Cr)
Fresh Issue
10,890,000 shares (aggregating up to Rs.152.46 Cr)
Issue Type
Book Built Issue IPO
Listing At

Valiant Laboratories IPO Timeline (Tentative Schedule)

Tentative Date
Opening Date
Wednesday, September 27, 2023
Closing Date
Tuesday, October 3, 2023
Basis of Allotment
Thursday, October 5, 2023
Initiation of Refunds
Friday, October 6, 2023
Credit of Shares to Demat
Friday, October 6, 2023
Listing Date
Monday, October 9, 2023
Cut-off time for UPI mandate confirmation
5 PM on October 3, 2023


Prospectus File

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508

* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.

© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.